NOVONORM 2MG X 30 TABS

NOVONORM 2 mg Tablets
Active Ingredient: Repaglinide 2 mg
Pack Size: 30 Tablets
Therapeutic Class: Oral Antidiabetic – Meglitinide Derivative

Description:
NOVONORM contains repaglinide, a fast-acting oral antidiabetic agent used to manage type 2 diabetes mellitus. It stimulates insulin secretion from the pancreas, especially around mealtimes, thereby helping to reduce postprandial (after meal) blood glucose levels.

Indications:

• Treatment of type 2 diabetes in adults, particularly where blood sugar control cannot be achieved by diet and exercise alone.

• Often used in combination with other antidiabetic medications like metformin.

Dosage and Administration:

• The typical starting dose is 0.5 to 1 mg before each main meal.

• For patients previously treated with other oral hypoglycemic agents, the starting dose may be 1–2 mg.

• Dose adjustments are based on individual response, up to a maximum of 4 mg per meal (16 mg/day).

• Should be taken 15–30 minutes before meals.

Contraindications:

• Type 1 diabetes mellitus

• Diabetic ketoacidosis

• Severe liver dysfunction

• Hypersensitivity to repaglinide or any component of the product

Warnings and Precautions:

• Risk of hypoglycemia, especially if meals are skipped or delayed.

• Not recommended during pregnancy or breastfeeding.

• Use with caution in patients with hepatic impairment.

• Monitor blood glucose levels regularly.

Possible Side Effects:

• Hypoglycemia

• Headache

• Gastrointestinal discomfort

• Upper respiratory tract infections

• Joint pain

Storage:
Store below 25°C in a dry place, away from direct sunlight and moisture.